Company Description
Welcome to the overview page for DFTX (DFTX), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
Latest News
SEC Filings
No SEC filings available for DFTX.
Financial Highlights
—
Revenue (TTM)
—
Net Income (TTM)
—
Operating Cash Flow
Upcoming Events
JAN
14
January 14, 2026
Marketing
J.P. Morgan webcast
Webcast of company presentation at the J.P. Morgan Healthcare Conference.
JAN
15
January 15, 2026
Corporate
Ticker change to DFTX
Begins trading on Nasdaq under ticker DFTX at market open; shareholders need not act.
APR
01
April 1, 2026 - June 30, 2026
Clinical
Voyage Phase 3 topline
Voyage Phase 3 topline readout (1st GAD study); topline readout window Q2 2026.
MAY
01
May 1, 2026 - August 31, 2026
Clinical
Emerge Phase 3 topline
Emerge Phase 3 topline readout (1st MDD study); expected mid‑year 2026.
JUL
01
July 1, 2026 - December 31, 2026
Clinical
Panorama Phase 3 topline
Panorama Phase 3 topline readout (2nd GAD study); readout expected in 2H 2026.
Short Interest History
Last 12 Months
Loading short interest data...
Days to Cover History
Last 12 Months
Loading days to cover data...